These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1695080)

  • 1. Flow cytometric analysis of proteoglycan expression on murine tumor cells with different metastatic capacity.
    Timár J; Lapis K
    Anticancer Res; 1990; 10(3):785-7. PubMed ID: 1695080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
    Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
    Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic phenotype: growth factor dependence and integrin expression.
    Perrotti D; Cimino L; Falcioni R; Tibursi G; Gentileschi MP; Sacchi A
    Anticancer Res; 1990; 10(6):1587-97. PubMed ID: 2285230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.
    Sekiguchi RT; Potter-Perigo S; Braun K; Miller J; Ngo C; Fukuchi K; Wight TN; Kimata K; Snow AD
    J Neurosci Res; 1994 Aug; 38(6):670-86. PubMed ID: 7807583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
    Yeaman C; Rapraeger AC
    J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of exogenous heparan sulfate with tumor cells of different metastatic phenotype.
    Timar J; Moczar M; Lapis K; Moczar E
    Invasion Metastasis; 1990; 10(5):301-15. PubMed ID: 2228518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-induced phosphorylation of a murine tumor surface protein (TSP-180) associated with metastatic phenotype.
    Sacchi A; Falcioni R; Piaggio G; Gianfelice MA; Perrotti N; Kennel SJ
    Cancer Res; 1989 May; 49(10):2615-20. PubMed ID: 2713845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of monoclonal antibody 155.8 and partial characterization of its proteoglycan antigen on human melanoma cells.
    Harper JR; Bumol TF; Reisfeld RA
    J Immunol; 1984 Apr; 132(4):2096-104. PubMed ID: 6199423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of metastasis-associated characteristics of tumor cells with different metastatic capacities].
    Shen Y; Vogel I; Kalthoff H
    Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):201-4. PubMed ID: 11778231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteoglycans on normal and migrating human corneal endothelium.
    Davies Y; Lewis D; Fullwood NJ; Nieduszynski IA; Marcyniuk B; Albon J; Tullo A
    Exp Eye Res; 1999 Mar; 68(3):303-11. PubMed ID: 10079138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
    Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
    Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression and distribution of heparan sulfate proteoglycans in human gliomas.
    Steck PA; Moser RP; Bruner JM; Liang L; Freidman AN; Hwang TL; Yung WK
    Cancer Res; 1989 Apr; 49(8):2096-103. PubMed ID: 2522816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-protein involvement in matrix-mediated motility and invasion of high and low experimental metastatic B16 melanoma clones.
    Lester BR; McCarthy JB; Sun ZQ; Smith RS; Furcht LT; Spiegel AM
    Cancer Res; 1989 Nov; 49(21):5940-8. PubMed ID: 2477150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen.
    Hooper JD; Zijlstra A; Aimes RT; Liang H; Claassen GF; Tarin D; Testa JE; Quigley JP
    Oncogene; 2003 Mar; 22(12):1783-94. PubMed ID: 12660814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poorly metastatic tumor cell variants as primary targets of syngeneic antibody responses against murine melanoma.
    Parratto NP; Odebralski JM; Kimura AK
    Cancer Res; 1989 Jul; 49(14):3722-8. PubMed ID: 2736512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of thrombin RGD in metastasis: characterization of a cryptic adhesive site.
    Bar-Shavit R; Ginzburg Y; Maoz M; Vlodavsky I; Peretz T
    Isr J Med Sci; 1995; 31(2-3):86-94. PubMed ID: 7744600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of tumor cell dissemination patterns in preclinical models of cancer metastasis using flow cytometry and laser scanning cytometry.
    Goodale D; Phay C; Postenka CO; Keeney M; Allan AL
    Cytometry A; 2009 Apr; 75(4):344-55. PubMed ID: 18855920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines.
    Giacomini P; Giorda E; Fraioli R; Nicotra MR; Vitale N; Setini A; Delfino L; Morabito A; Benevolo M; Venturo I; Mottolese M; Ferrara GB; Natali PG
    Cancer Res; 1999 Jun; 59(11):2657-67. PubMed ID: 10363989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heparan sulfate-specific epitope 10E4 is NO-sensitive and partly inaccessible in glypican-1.
    Mani K; Cheng F; Sandgren S; Van Den Born J; Havsmark B; Ding K; Fransson LA
    Glycobiology; 2004 Jul; 14(7):599-607. PubMed ID: 15044385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.